GB202004844D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB202004844D0
GB202004844D0 GBGB2004844.3A GB202004844A GB202004844D0 GB 202004844 D0 GB202004844 D0 GB 202004844D0 GB 202004844 A GB202004844 A GB 202004844A GB 202004844 D0 GB202004844 D0 GB 202004844D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2004844.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Therapeutics AS
Original Assignee
Union Therapeutics AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Therapeutics AS filed Critical Union Therapeutics AS
Priority to GBGB2004844.3A priority Critical patent/GB202004844D0/en
Publication of GB202004844D0 publication Critical patent/GB202004844D0/en
Priority to US17/097,898 priority patent/US11045434B1/en
Priority to CA3173163A priority patent/CA3173163A1/en
Priority to PCT/EP2021/058046 priority patent/WO2021198115A1/en
Priority to EP21715583.7A priority patent/EP4125805A1/en
Priority to EP21715582.9A priority patent/EP4125804A1/en
Priority to JP2022560085A priority patent/JP2023520229A/en
Priority to BR112022019519A priority patent/BR112022019519A2/en
Priority to IL296898A priority patent/IL296898A/en
Priority to MX2022012359A priority patent/MX2022012359A/en
Priority to CA3172166A priority patent/CA3172166A1/en
Priority to US17/995,079 priority patent/US20230147683A1/en
Priority to US17/995,053 priority patent/US20230190685A1/en
Priority to MX2022012360A priority patent/MX2022012360A/en
Priority to IL296909A priority patent/IL296909A/en
Priority to AU2021247378A priority patent/AU2021247378A1/en
Priority to KR1020227038248A priority patent/KR20230020952A/en
Priority to KR1020227038253A priority patent/KR20230024883A/en
Priority to BR112022019521A priority patent/BR112022019521A2/en
Priority to PCT/EP2021/058047 priority patent/WO2021198116A1/en
Priority to JP2022560369A priority patent/JP2023520542A/en
Priority to CN202180036954.6A priority patent/CN115701984A/en
Priority to CN202180035793.9A priority patent/CN115701983A/en
Priority to AU2021248603A priority patent/AU2021248603A1/en
Priority to US17/330,067 priority patent/US11324708B1/en
Priority to US17/723,079 priority patent/US20220323384A1/en
Ceased legal-status Critical Current

Links

GBGB2004844.3A 2020-04-01 2020-04-01 Treatment Ceased GB202004844D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB2004844.3A GB202004844D0 (en) 2020-04-01 2020-04-01 Treatment
US17/097,898 US11045434B1 (en) 2020-04-01 2020-11-13 Niclosamide formulations for treating disease
AU2021248603A AU2021248603A1 (en) 2020-04-01 2021-03-26 Treatment
US17/995,053 US20230190685A1 (en) 2020-04-01 2021-03-26 Formulation
AU2021247378A AU2021247378A1 (en) 2020-04-01 2021-03-26 Formulation
EP21715583.7A EP4125805A1 (en) 2020-04-01 2021-03-26 Formulation
EP21715582.9A EP4125804A1 (en) 2020-04-01 2021-03-26 Treatment
JP2022560085A JP2023520229A (en) 2020-04-01 2021-03-26 pharmaceutical formulation
BR112022019519A BR112022019519A2 (en) 2020-04-01 2021-03-26 TREATMENT
IL296898A IL296898A (en) 2020-04-01 2021-03-26 Treatment
MX2022012359A MX2022012359A (en) 2020-04-01 2021-03-26 Formulation.
CA3172166A CA3172166A1 (en) 2020-04-01 2021-03-26 Formulation
US17/995,079 US20230147683A1 (en) 2020-04-01 2021-03-26 Treatment
CA3173163A CA3173163A1 (en) 2020-04-01 2021-03-26 Treatment
MX2022012360A MX2022012360A (en) 2020-04-01 2021-03-26 Treatment.
IL296909A IL296909A (en) 2020-04-01 2021-03-26 Formulation
PCT/EP2021/058046 WO2021198115A1 (en) 2020-04-01 2021-03-26 Treatment
KR1020227038248A KR20230020952A (en) 2020-04-01 2021-03-26 therapy
KR1020227038253A KR20230024883A (en) 2020-04-01 2021-03-26 formulation
BR112022019521A BR112022019521A2 (en) 2020-04-01 2021-03-26 FORMULATION
PCT/EP2021/058047 WO2021198116A1 (en) 2020-04-01 2021-03-26 Formulation
JP2022560369A JP2023520542A (en) 2020-04-01 2021-03-26 therapeutic drug
CN202180036954.6A CN115701984A (en) 2020-04-01 2021-03-26 Treatment of
CN202180035793.9A CN115701983A (en) 2020-04-01 2021-03-26 Formulations
US17/330,067 US11324708B1 (en) 2020-04-01 2021-05-25 Niclosamide formulations for treating disease
US17/723,079 US20220323384A1 (en) 2020-04-01 2022-04-18 Niclosamide formulations for treating disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2004844.3A GB202004844D0 (en) 2020-04-01 2020-04-01 Treatment

Publications (1)

Publication Number Publication Date
GB202004844D0 true GB202004844D0 (en) 2020-05-13

Family

ID=70553515

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2004844.3A Ceased GB202004844D0 (en) 2020-04-01 2020-04-01 Treatment

Country Status (1)

Country Link
GB (1) GB202004844D0 (en)

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202116743D0 (en) Treatment
GB202114373D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202101897D0 (en) Treatment
GB202101875D0 (en) Treatment
GB202101211D0 (en) Treatment
GB202101212D0 (en) Treatment
GB202101213D0 (en) Treatment
GB202101210D0 (en) Treatment
GB202100976D0 (en) Treatment
GB202020157D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)